SEC Filings
Polar Capital Holdings Reports 5.19% Of Xenon Shares With A Passive-Control Certification
The holding company and investment adviser Polar Capital LLP each reported the same 5,022,084-share position.
Xenon Pharmaceuticals (XENE) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The holding company and investment adviser Polar Capital LLP each reported the same 5,022,084-share position.
Earnings
A voluntary enrollment pause makes safety findings central to the next decision on azetukalner.
Earnings
Loss per share narrowed, while initial results from the completed depression-study enrollment are now expected in December.
SEC Filings
The investment manager reported 7,905,757 shares, with sole voting authority covering 7,558,551 shares.